Allele and Genotype Frequencies of CYP2B6 and CYP2C19 Polymorphisms in Egyptian Agricultural Workers
- 15 February 2012
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Toxicology and Environmental Health, Part A
- Vol. 75 (4), 232-241
- https://doi.org/10.1080/15287394.2012.641201
Abstract
Genetic variability in cytochrome P-450 (CYP) has the potential to modify pharmacological and toxicological responses to many chemicals. Both CYP2B6 and CYP2C19 are pharmacologically and toxicologically relevant due to their ability to metabolize multiple drugs and environmental contaminants, including the organophosphorus (OP) pesticide chlorpyrifos. The aim of this study was to determine the prevalence of CYP2B6 and CYP2C19 variants in an indigenous Egyptian population (n = 120) that was shown to be occupationally exposed to chlorpyrifos. Further, the genotyping data was compared for Egyptians with previously studied populations to determine between population differences. Allelic frequencies were CYP2B6 1459C > T (3.8%), CYP2B6 785A > G (30.4%), CYP2B6 516G > T (28.8%), CYP2C19 681G > A (3.8%), and CYP2C19 431G > A (0%). The most prevalent CYP2B6 genotype combinations were CYP2B6 *1/*1 (44%), *1/*6 (38%), *6/*6 (8%), and *1/*5 (6%). The frequency of the CYP2C19 genotype combinations were CYP2C19 *1/*1 (93%), *1/*2 (6%), and *2/*2 (1%). The frequency of the CYP2B6 516G > T and CYP2B6 785A > G polymorphisms in this Egyptian cohort is similar to that found North American and European populations but significantly different from that reported for West African populations, while that of CYP2B6 1459C > T is similar to that found in Africans and African Americans. The observed frequency of CYP2C19 681G > A in Egyptians is similar to that of African pygmies but significantly different from other world populations, while CYP2C19 431 G > A was significantly different from that of African pygmies but similar to other world populations.Keywords
This publication has 49 references indexed in Scilit:
- Human Hepatic Cytochrome P450-Specific Metabolism of the Organophosphorus Pesticides Methyl Parathion and DiazinonDrug Metabolism and Disposition, 2011
- Q172H Replacement Overcomes Effects on the Metabolism of Cyclophosphamide and Efavirenz Caused by CYP2B6 Variant with Arg262Drug Metabolism and Disposition, 2011
- Biomarkers of Chlorpyrifos Exposure and Effect in Egyptian Cotton Field WorkersEnvironmental Health Perspectives, 2011
- Chlorpyrifos exposures in Egyptian cotton field workersNeuroToxicology, 2010
- Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian populationBMC Medical Genetics, 2009
- Human Hepatic Cytochrome P450-Specific Metabolism of Parathion and ChlorpyrifosDrug Metabolism and Disposition, 2006
- Intestinal and Hepatic Metabolic Activity of Five Cytochrome P450 Enzymes: Impact on Prediction of First-Pass MetabolismThe Journal of pharmacology and experimental therapeutics, 2006
- The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic ActivityThe Journal of pharmacology and experimental therapeutics, 2003
- S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among EthiopiansPharmacogenetics, 1996
- Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsPharmacogenetics, 1992